1983PubMedRequires access

Continuous infusion of physostigmine in anticholinergic delirium: case report.

Theodore A. Stern

Open publisher page 20 citations

Abstract

A continuous intravenous infusion of physostigmine was successfully used in the management of a case of anticholinergic poisoning. In selected patients, intravenous physostigmine can be a safe and specific means of reversing the signs and symptoms of anticholinergic toxicity.

About this research paper

What this paper is about

A continuous intravenous infusion of physostigmine was successfully used in the management of a case of anticholinergic poisoning. In selected patients, intravenous physostigmine can be a safe and specific means of reversing the signs and symptoms of anticholinergic toxicity.

Why it matters

OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A continuous intravenous infusion of physostigmine was successfully used in the management of a case of anticholinergic poisoning. In selected patients, intravenous physostigmine can be a safe and specific means of reversing the signs and symptoms of anticholinergic toxicity.

Key concepts: Physostigmine, Anticholinergic, Delirium, Anesthesia, Medicine, Anticholinergic agents, Toxicity, Intensive care medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Continuous infusion of physostigmine in anticholinergic delirium: case report. — Research Paper | ScholarLens